NCT05212116 - A Study of SDI-118 in Participants in Remission From Depression | Biotech Hunter

Timeline

Start Date

September 16, 2021

Primary Completion Date

March 11, 2022

Study Completion Date

March 11, 2022

Conditions

Depression in Remission

Interventions

DRUG

SDI-118

SDI-118 is presented as low dose, and high dose capsules.

DRUG

Placebo

The Matching Placebo for SDI-118 is mannitol in capsules.

Trial Locations (3)

University of Manchester, Manchester

University of Oxford, Oxford

Cardiff University, Cardiff